LEADER 03820nam 2201093z- 450 001 9910557103303321 005 20231214133356.0 035 $a(CKB)5400000000041014 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/69181 035 $a(EXLCZ)995400000000041014 100 $a20202105d2020 |y 0 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aMarine-Derived Products for Biomedicine 210 $aBasel, Switzerland$cMDPI - Multidisciplinary Digital Publishing Institute$d2020 215 $a1 electronic resource (214 p.) 311 $a3-03943-130-7 311 $a3-03943-131-5 330 $aThe sustainable exploitation of marine biodiversity is one structural column of the ?blue economy?, and the discovery of new compounds and materials to be used in biomedicine is considered one of the most strategic activities, within an economic context. An exhaustive selection of the different typologies of approaches used by marine biotechnologists to develop research on these topics are demonstrated in the eight original articles and two reviews comprising this Special Issue. The reported scientific publications describe the discovery of new compounds for cancer therapy or for the control of bacterial virulence. Different new uses of marine chitin or chitosan-based materials are also shown for the first time, as well as novel green techniques for the extraction of compounds from marine algae or from fishery waste, which are described in the two reviews. 606 $aTechnology: general issues$2bicssc 610 $aExtracellular Polymeric Substances 610 $ahydrogel 610 $amesenchymal stem cells 610 $abiomaterials 610 $aenzyme 610 $aomega 3 610 $aPUFA 610 $aTrichormus variabilis 610 $aCyanobacteria 610 $amechanochemical synthesis 610 $achitosan 610 $alaser stereolithography 610 $along-term stability 610 $ascaffold 610 $atissue reaction 610 $achitin 610 $ascaffolds 610 $abiological materials 610 $ademosponges 610 $aPseudoceratina arabica 610 $amicroalgae 610 $abiodiversity 610 $abioactive compounds 610 $agreen extractions 610 $apharmaceutical 610 $asecondary metabolites 610 $abiofuels 610 $aantibiofilm 610 $afucoidan 610 $amotility 610 $ananoparticles 610 $aPseudomonas aeruginosa 610 $avirulence factors 610 $an-3 fatty acids 610 $abrain 610 $a?-Chitin 610 $aprodigiosin 610 $aanti-tumors 610 $aSerratia marcescens 610 $abioprocessing 610 $aechinochrome A 610 $aestradiol 610 $aextracellular matrix 610 $avocal fold 610 $aovariectomy 610 $amarine polymers 610 $aionic liquids 610 $atissue engineering 610 $amembranes 610 $ahydrogels 610 $asponges 610 $aChondrosin 610 $aChondrosia reniformis 610 $amarine toxin 610 $acytotoxic protein 610 $aPorifera 610 $amarine 610 $amicrobes 610 $acancer 610 $aprevention 610 $atherapy 610 $ain vitro 610 $ain vivo 610 $aclinical studies 615 7$aTechnology: general issues 700 $aGiovine$b Marco$4edt$01320354 702 $aGiovine$b Marco$4oth 906 $aBOOK 912 $a9910557103303321 996 $aMarine-Derived Products for Biomedicine$93034179 997 $aUNINA